New approaches in managing drug overdosage and poisoning.
D000082:Acetaminophen / Q000506:poisoning; D000111:Acetylcysteine / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000506:poisoning; D000328:Adult; D000701:Analgesics, Opioid / Q000506:poisoning; D002648:Child; D002800:Cholinesterase Inhibitors / Q000506:poisoning; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007408:Intestinal Absorption / Q000187:drug effects; D008715:Methionine / Q000627:therapeutic use; D009270:Naloxone / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D011041:Poisoning / Q000628:therapy*; D011042:Poisons / Q000378:metabolism; D012646:Self Administration
D000319:Adrenergic beta-Antagonists; D000701:Analgesics, Opioid; D002800:Cholinesterase Inhibitors; D011042:Poisons; D000082:Acetaminophen; D009270:Naloxone; D005934:Glucagon; D010830:Physostigmine; D008715:Methionine; D000111:Acetylcysteine